Related Experiment Video
Updated: Aug 15, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Phenotype of ENAM mutations is dosage-dependent
D Ozdemir1, P S Hart, E Firatli
1Clinical Research Core, NIDCR/National Institutes of Health, 10 Center Drive, Building 10, Room 5-2531, Bethesda, MD 20892-1432, USA.
Mutations in the ENAM gene cause enamel defects. This study found new ENAM mutations in Turkish families, showing that enamel pitting and hypoplastic amelogenesis imperfecta can be dose-dependent genetic traits.
Area of Science:
- Genetics
- Oral Biology
- Developmental Biology
Background:
- Amelogenesis imperfecta (AI) is a group of inherited dental disorders affecting tooth enamel formation.
- Mutations in the ENAM gene, encoding enamelin, are a known cause of hypoplastic AI.
- The spectrum of ENAM-related phenotypes, particularly the dose-dependency, requires further investigation.
Observation:
- This study investigated ENAM gene mutations in ten Turkish families with autosomal hypoplastic AI.
- ENAM mutations were identified in two families, revealing novel and previously described genetic alterations.
- Specific mutations correlated with distinct inheritance patterns and phenotypic severity.
Findings:
- A novel nonsense mutation (p.S246X) in ENAM caused dominant autosomal hypoplastic AI with localized enamel pitting.
- Compound heterozygosity for two insertion mutations in ENAM resulted in autosomal-recessive generalized hypoplastic AI.
- Heterozygous carriers of insertion mutations exhibited a localized enamel-pitting phenotype, suggesting a dose-dependent effect.
Implications:
- These findings confirm ENAM mutations as a significant cause of hypoplastic AI across different populations.
- The study highlights the dose-dependent nature of ENAM mutations, explaining varied phenotypes from localized pitting to severe hypoplasia.
- Understanding genotype-phenotype correlations in ENAM mutations is crucial for genetic counseling and potential therapeutic strategies.
More Related Videos
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Dosage Compensation
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will have...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

